Virtue Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.24M Buy
+62,063
New +$6.37M 0.81% 27
2026
Q2
– Sell
-76,344
Closed -$6.43M – 363
2026
Q1
$6.43M Buy
+76,344
New +$6.68M 0.98% 25
2024
Q2
– Sell
-77,546
Closed -$4.98M – 403
2024
Q1
$4.98M Buy
+77,546
New +$5.13M 0.89% 25

Other funds holding IHE

Virtue Capital Management's IHE Position: Q3 2026 in Review

Virtue Capital Management opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 62,063 shares worth $6.24M. The stake represents 0.81% of the portfolio and ranks #27 among its holdings. This is a return to the name: Virtue Capital Management previously reported a position in IHE as recently as Q1 2026.

Virtue Capital Management first reported a position in IHE in Q1 2024 and has held it in 3 quarters since. The position peaked at $6.43M in Q1 2026. 249 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • Virtue Capital Management held 62,063 shares of iShares US Pharmaceuticals ETF worth $6.24M as of Q3 2026.
  • iShares US Pharmaceuticals ETF was a new Virtue Capital Management position in Q3 2026.
  • iShares US Pharmaceuticals ETF made up 0.81% of Virtue Capital Management's portfolio in Q3 2026, its #27 holding.
  • Virtue Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2024 and has held it in 3 quarters since.
  • Virtue Capital Management's iShares US Pharmaceuticals ETF position peaked at $6.43M in Q1 2026.
  • 249 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Virtue Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.